Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-25 of 94 for your search:
Drug:
ifosfamide
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III/IV Randomized Study of Risk-Adapted Therapy Comprising Observation Only, Combination Chemotherapy, Radiotherapy, and/or Autologous Stem Cell Transplantation in Younger Patients With Neuroblastoma
Phase:
Phase IV, Phase III
Type:
Treatment
Status:
Active
Age:
21 and under
Sponsor:
Other
Protocol IDs:
GPOH-NB2004
, EU-20661, NCT00410631
2.
Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-Grade Lymphoma in Adults
Phase:
Phase IV
Type:
Treatment
Status:
Active
Age:
Over 15
Sponsor:
Other
Protocol IDs:
GMALL05
, NCT00199082
3.
Phase II/III Randomized Study of Carboplatin and Ifosfamide With or Without Whole Body Hyperthermia in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Extraovarian Peritoneal Cancer
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 to 65
Sponsor:
Other
Protocol IDs:
LMU-DOLPHIN-1
, EU-20220, NCT00045461
4.
Phase III Randomized Study of Sequential Chemotherapy With or Without Rituximab Followed By Ablative Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation in Patients With Relapsed, CD20 Positive, Aggressive B-Cell Non-Hodgkin's Lymphoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 to 65
Sponsor:
Other
Protocol IDs:
CKTO-2000-06
, HOVON-44, HOVON-44/CKVO-2000-06, EU-20042, ISRCTN95614846, NCT00012051
5.
Phase III Randomized Study of Standard Induction Chemotherapy Comprising Vincristine, Dactinomycin, Ifosfamide, and Etoposide Followed By Consolidation Chemotherapy Comprising Vincristine, Dactinomycin, and Ifosfamide Versus High-Dose Busulfan and Melphalan Followed By Autologous Peripheral Blood Stem Cell Support With or Without Radiotherapy and/or Surgery in Patients With Tumor of the Ewing's Family
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 50
Sponsor:
NCI, Other
Protocol IDs:
EURO-EWING-INTERGROUP-EE99
, EBMT-INTERGROUP-EE99, EORTC-62981, GPOH-AUSTRIA-INTERGROUP-EE99, GPOH-GERMANY-INTERGROUP-EE99, SFOP-INTERGROUP-EE99, SWS-SAKK-INTERGROUP-EE99, CCLG-INTERGROUP-EE99, COG-AEWS0331, NCT00020566, AEWS0331
6.
Phase III Randomized Study of Doxorubicin With Versus Without Ifosfamide and Pegfilgrastim in Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 to 60
Sponsor:
Other
Protocol IDs:
EORTC-62012
, NCT00061984
7.
Phase III Randomized Study of Bleomycin, Etoposide, and Cisplatin With or Without Dose-Dense Sequential Combination Chemotherapy in Patients With Poor Prognosis Stage II or III Non-Seminomatous Germ Cell Tumors
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Over 16
Sponsor:
Other
Protocol IDs:
FRE-FNCLCC-GETUG-13/0206
, EU-20502, NCT00104676
8.
Phase III Randomized Study of Neoadjuvant Induction Therapy Comprising Doxorubicin, Cisplatin, and High-Dose Methotrexate (MAP) Followed by Surgery and Adjuvant Maintenance Therapy Comprising MAP Alone Versus MAP and PEG-Interferon Alfa-2b OR MAP Combined With Ifosfamide and Etoposide in Patients With Resectable High-Grade Osteosarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
5 to 40 at diagnostic biopsy
Sponsor:
NCI
Protocol IDs:
COG-AOST0331
, AOST0331, NCT00134030, ISRCTN67613327, EU-20530, MRC-EURAMOS1, MRC-BO08, EUDRACT-2004-000242-20
9.
Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 to 65
Sponsor:
Other
Protocol IDs:
119 of 2003
, NCT00193739
10.
Phase III Study of Ifosfamide and Doxorubicin Hydrochloride, Radiotherapy, and/or Surgery in Patients With Localized Non-Rhabdomyosarcoma Soft Tissue Sarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 21
Sponsor:
Other
Protocol IDs:
CCLG-EPSSG-NRSTS-2005
, EU-20620, EUDRACT-2005-001139-31, UKCCSG-CTA-21275/0215/001/0001, CCLG-EpSSG-STS-2006-03, NCT00334854
11.
Phase III Study of Risk-Based Therapy Comprising Observation Only, Adjuvant Radiotherapy, or Adjuvant Chemoradiotherapy or Neoadjuvant Chemoradiotherapy, Surgery, and Adjuvant Chemotherapy With or Without Radiotherapy in Young Patients With Non-Rhabdomyosarcoma Soft Tissue Sarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 30 at diagnosis
Sponsor:
NCI
Protocol IDs:
COG-ARST0332
, ARST0332, NCT00346164
12.
Phase III Randomized Study of Ifosfamide, Vincristine, and Dactinomycin With or Without Doxorubicin in Pediatric Patients With Non-Metastatic Rhabdomyosarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 21
Sponsor:
Other
Protocol IDs:
CCLG-EPSSG-RMS-2005
, EU-20639, EUDRACT-2005-000217-35, UKCCSG-RMS-2005, NCT00379457
13.
Phase III Randomized Study of Risk-Adjusted Therapies in Pediatric Patients With Acute Lymphoblastic Leukemia (All Randomized Treatment Arms Closed to Accrual as of 6/30/2006)
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
1 to 18
Sponsor:
Other
Protocol IDs:
ALL-BFM-2000
, EU-20682, NCT00430118
14.
Phase III Randomized Study of Combination Chemotherapy in Pediatric Patients With Hodgkin's Lymphoma
Phase:
Phase III
Type:
Diagnostic, Treatment
Status:
Active
Age:
Under 18
Sponsor:
Other
Protocol IDs:
EURONET-PHL-C1
, EU-20703, EUDRACT-2006-000995-33, NCT00433459, CCLG-HD-2007-10
15.
Phase III Randomized Study of Combination Chemotherapy With or Without Zoledronic Acid in Patients With Osteosarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
5 to 50
Sponsor:
Other, Pharmaceutical / Industry
Protocol IDs:
FRE-FNCLCC-SARCOME-09-0603
, FRE-FNCLCC-OS-2006, NOVARTIS-FRE-FNCLCC-SARCOME-09-0603, CHUGAI-FRE-FNCLCC-SARCOME-09-0603, EU-20729, EUDRACT-2006-00337727, SARCOME 09/0603, NCT00470223
16.
The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 to 65
Sponsor:
Other
Protocol IDs:
SARC-GYN1
, NCT00162721
17.
Multi Centre Trial of DSMM for Newly Diagnosed Multiple Myeloma up to 60 Years
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 to 60
Sponsor:
Other
Protocol IDs:
DSMM V
, NCT00546988
18.
Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas
Phase:
Phase III
Type:
Diagnostic, Treatment
Status:
Active
Age:
18 to 80
Sponsor:
Other
Protocol IDs:
PETAL trial
, EudraCT-Number 2006-001641-33, Krebshilfe Grant 107592, NCT00554164
19.
Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors
Phase:
Phase III
Type:
Supportive care, Treatment
Status:
Active
Age:
15 and over
Sponsor:
Other
Protocol IDs:
QL05-37
, NCT00572572
20.
A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
30 and under
Sponsor:
NCI, Other
Protocol IDs:
OS2008
, NCT00667342
21.
Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
ELCWP 01994
, NCT00658580
22.
Phase III Study of Dasatinib in Combination With Intensified Chemotherapy in Young Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
1 to 30
Sponsor:
NCI
Protocol IDs:
COG-AALL0622
, AALL0622, NCT00720109
23.
Phase III Randomized Study of Risk-Adjusted Management in Pediatric Patients With Acute Lymphoblastic Leukemia
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and under
Sponsor:
Other
Protocol IDs:
MOTOL-ALL-IC-BFM-2002
, ALL-IC-BFM-2002, EU-20871, NCT00764907
24.
A Study of the Safety and Effectiveness of Trabetedin Versus Doxorubicin-based Chemotherapy in Patients With Translocation-Related Sarcomas (TRS)
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
CR015769
, NCT00796120
25.
Phase III Study of Three Different Therapeutic Strategies in Patients With Previously Untreated Hodgkin Lymphoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 to 65
Sponsor:
Other
Protocol IDs:
GOELAMS-LH2007
, GOELAMS LH2007, GOELAMS-ID-RCB#2007-A01079-44, INCA-RECF0754, AMGEN-GOELAMS-LH2007, NCT00920153
Select All on Page
1
Help with Results
